Lymphocyte-to-monocyte ratio and risk of hemorrhagic transformation in patients with acute ischemic stroke

[1] Benjamin EJ(2019)Heart disease and stroke statistics-2019 update: a report from the American Heart Association Circulation 139 e56-e66

[2] Muntner P(2007)Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry Stroke 38 75-79

[3] Alonso A(2012)Is asymptomatic hemorrhagic transformation really innocuous? Neurology 78 421-426

[4] Bittencourt MS(2014)Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials Stroke 45 2728-2733

[5] Callaway CW(2014)Hemorrhagic transformation after ischemic stroke in animals and humans J Cereb Blood Flow Metab 34 185-199

[6] Carson AP(2018)Neutrophil-lymphocyte ratio predicts functional and safety outcomes after endovascular treatment for acute ischemic stroke Cerebrovasc Dis 45 221-227

[7] Chamberlain AM(2016)Dynamic change of neutrophil to lymphocyte ratio and hemorrhagic transformation after thrombolysis in stroke J Neuroinflammation 13 199-1791

[8] Chang AR(2015)T cells and cerebral ischemic stroke Neurochem Res 40 1786-1002

[9] Cheng S(2009)Monocyte subtypes predict clinical course and prognosis in human stroke J Cereb Blood Flow Metab 29 994-199

[10] Das SR(2009)Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke Nat Med 15 192-467

[1] Benjamin EJ(2019)Heart disease and stroke statistics-2019 update: a report from the American Heart Association Circulation 139 e56-e66

[2] Muntner P(2007)Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry Stroke 38 75-79

[3] Alonso A(2012)Is asymptomatic hemorrhagic transformation really innocuous? Neurology 78 421-426

[4] Bittencourt MS(2014)Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials Stroke 45 2728-2733

[5] Callaway CW(2014)Hemorrhagic transformation after ischemic stroke in animals and humans J Cereb Blood Flow Metab 34 185-199

[6] Carson AP(2018)Neutrophil-lymphocyte ratio predicts functional and safety outcomes after endovascular treatment for acute ischemic stroke Cerebrovasc Dis 45 221-227

[7] Chamberlain AM(2016)Dynamic change of neutrophil to lymphocyte ratio and hemorrhagic transformation after thrombolysis in stroke J Neuroinflammation 13 199-1791

[8] Chang AR(2015)T cells and cerebral ischemic stroke Neurochem Res 40 1786-1002

[9] Cheng S(2009)Monocyte subtypes predict clinical course and prognosis in human stroke J Cereb Blood Flow Metab 29 994-199

[10] Das SR(2009)Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke Nat Med 15 192-467